(Q39110163)

9 September 2017

Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches (English)

1 reference

9 September 2017

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28137665%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Carmela Rita Balistreri

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28137665%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

4

Raffaele De Caterina

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28137665%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

3

Yong-Jian Geng

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28137665%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

27 January 2017

1 reference

9 September 2017

Vascular Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28137665%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28137665%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

1-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28137665%20AND%20SRC:MED&resulttype=core&format=json

Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Cellular and molecular mechanisms of vascular injury in diabetes--part II: cellular mechanisms and therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Osmotic response element enhancer activity. Regulation through p38 kinase and mitogen-activated extracellular signal-regulated kinase kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

High glucose-induced hyperosmolarity contributes to COX-2 expression and angiogenesis: implications for diabetic retinopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

The role of hyperosmotic stress in inflammation and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Vascular wall progenitor cells in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Characterization of a resident population of adventitial macrophage progenitor cells in postnatal vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Vascular smooth muscle progenitor cells: building and repairing blood vessels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Vascular wall resident progenitor cells: a source for postnatal vasculogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Cellular and molecular basis of the imbalance between vascular damage and repair in ageing and age-related diseases: As biomarkers and targets for new treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

NF-κB pathway activators as potential ageing biomarkers: targets for new therapeutic strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

The emerging role of Notch pathway in ageing: Focus on the related mechanisms in age-related diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Notch signaling protects retina from nuclear factor-κB- and poly-ADP-ribose-polymerase-mediated apoptosis under high-glucose stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

High glucose-induced jagged 1 in endothelial cells disturbs notch signaling for angiogenesis: a novel mechanism of diabetic vasculopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Antagonizing Wnt pathway in diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Circulating endothelial progenitor cells: Do they live up to their name?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Severe Type 2 Diabetes Induces Reversible Modifications of Endothelial Progenitor Cells Which are Ameliorate by Glycemic Control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

The hematopoietic chemokine CXCL12 promotes integration of human endothelial colony forming cell-derived cells into immature vessel networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Vascular endothelial growth factor-A signaling in bone marrow-derived endothelial progenitor cells exposed to hypoxic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Enhanced Integrin α4β1-Mediated Adhesion Contributes to a Mobilization Defect of Endothelial Progenitor Cells in Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Angiopoietin-1 improves endothelial progenitor cell-dependent neovascularization in diabetic wounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Hyperglycaemia exerts deleterious effects on late endothelial progenitor cell secretion actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Dipeptidyl-peptidase 4 inhibition: linking metabolic control to cardiovascular protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Circulating smooth muscle progenitor cells contribute to atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Roles of SM22α in cellular plasticity and vascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Capillary pericytes regulate cerebral blood flow in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Pericytes and the pathogenesis of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Pericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

High Glucose-induced Retinal Pericyte Apoptosis Depends on Association of GAPDH and Siah1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Deletion of ocular transforming growth factor β signaling mimics essential characteristics of diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Biochemistry and molecular cell biology of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Do advanced glycation end products contribute to the development of long-term diabetic complications?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Soluble receptor for advanced glycation end-product levels are related to albuminuria and arterial stiffness in essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Hyperglycemia induces Toll-like receptor-2 and -4 expression and activity in human microvascular retinal endothelial cells: implications for diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

TLR4 links innate immunity and fatty acid-induced insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Evidences of +896 A/G TLR4 polymorphism as an indicative of prevalence of complications in T2DM patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Toll-like receptor 4 D299G polymorphism in metabolic disorders: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Impairment of insulin-mediated glucose metabolism by hyperosmolality in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Amelioration of hyperglycemic and hyperosmotic induced vascular dysfunction by in vivo inhibition of protein kinase C and p38 MAP kinase pathway in the rat mesenteric microcirculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

7 January 2021

Aquaporins at a glance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Aquaporin-1 is expressed by vascular smooth muscle cells and mediates rapid water transport across vascular cell membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Roles of a prostaglandin E-type receptor, EP3, in upregulation of matrix metalloproteinase-9 and vascular endothelial growth factor during enhancement of tumor metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Molecular bases of the acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

NFAT5 binds to the TNF promoter distinctly from NFATp, c, 3 and 4, and activates TNF transcription during hypertonic stress alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Hypertonic induction of COX-2 expression in renal medullary epithelial cells requires transactivation of the EGFR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Coordinate control of prostaglandin E2 synthesis and uptake by hyperosmolarity in renal medullary interstitial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Aquaporin-1 channel function is positively regulated by protein kinase C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Hypertonic saline solution induces prostacyclin production by increasing cyclooxygenase-2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Hypertonic induction of COX2 expression requires TonEBP/NFAT5 in renal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Polyoma virus-induced osteosarcomas in inbred strains of mice: host determinants of metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

NFAT3 is specifically required for TNF-alpha-induced cyclooxygenase-2 (COX-2) expression and transformation of Cl41 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Dietary Betaine Supplementation Increases Fgf21 Levels to Improve Glucose Homeostasis and Reduce Hepatic Lipid Accumulation in Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

10-year follow-up of intensive glucose control in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2017.01.004

10.1016/J.VPH.2017.01.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28137665%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference